

























aldosterone concentration : PAC）／血漿レニン活性
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１ ５４ F 難治性高血圧 低 ５２６ ０．１ ５，２６０ R 不明 未施行 ㊨ APA OP
２ ３３ F 若年性高血圧 ２．８ １５０ ０．１ １，５００ L 集積なし フロセミド ㊧ APA OP
３ ７３ M 副腎偶発腫瘍 ３．２ ３５２ ０．３ １，１７３ L L優位 フロセミド ㊧ APA OP
４ ６０ M 副腎偶発腫瘍 ３．２ １４０ ０．６ ２３３ L L優位 フロセミド ？ OP
５ ７５ M 難治性高血圧 ２．９ ５７５ ０．３ １，９１７ R R優位 ACTH ㊨ APA OP
６ ６０ M 副腎偶発腫瘍 ３．０ ２６７ ０．２ １，３３５ L L優位 フロセミドACTH* ㊧ APA OP
７ ５６ F 低カリウム血症副腎偶発腫瘍 ３．３ １０５ ０．２ ５２５ L 両側集積
未施行
ACTH* ㊧ APA 予定
８ ５８ M 難治性高血圧 ２．６ ２８４ ０．１ ２，８４０ R R優位 フロセミドACTH* ㊨ APA OP
９ ５３ M 副腎偶発腫瘍 ３．０ ２０８ ０．９ ２３１ R R優位 カプトプリルACTH* ㊨ APA OP
平均 ５８ 高血圧４例偶発腫瘍５例 ３．０ ２９０ ０．３ １，６６８
ACTH：副腎皮質刺激ホルモン，AVS：副腎静脈サンプリング
*ACTH負荷 AVSで末梢採血を追加して，迅速 ACTH負荷試験として兼用

































Aldo Corti A／C Aldo Corti A／C 右 左
２ L ７，２３０ ５３４ １３．５ ３０，０００ ９６．２ ３１２ ６２．１ １１．１
４ L － － － ６，５９０ １，８００ ３．７ － １１６
５ R ５６０，０００ ６２１ ９０１．８ ９８５ １３３．５ ７．４ ２８．０ ６．０
６ L ４５５ ３２．４ １４．０ ６５，０９０ ５３４ １２２ １．６ ２６．４
７ L １３，０３６ ６９６ １８．７ ４２，１８９ ６４０ ６５．９ ５５．７ ５１．２
８ R １５，５２２ １７６ ８８．２ ２，７８０ ６９０ ４．０ １１．４ ４４．８
９ R ３，１７１ ４５．２ ７０．２ ２，４６５ ４０９ ６．０ ２．４ ２１．９







（左副腎静脈） ACTH負荷後（右） ACTH負荷後（左） LR CR
Aldo Corti A／C Aldo Corti A／C Aldo Corti A／C Aldo Corti A／C
１ R ４，２２０ １５．３ ２７６ ２２３ １６．０ １３．９ n.d. n.d. n.d. n.d. n.d. n.d.
２ L ３８８ ５８．５ ６．６ １２，０００ ４５．７ ２６３ ７，２３０ ５３４ １３．５ ３０，０００ ９６．２ ３１２ ２４．５ ０．４
３ L ２６ ２．４ １０．８ ５０４ ５．９ ８５．４ n.d. n.d. n.d. n.d. n.d. n.d.
４ L ９６ ２３．１ ４．２ ７４３ ３４９ ２．１ × × × ６，５９０ １，８００ ３．７
５ R ６００，０００ ４６５ １，２９０ １２３ ９．７ １２．７ ５６０，０００ ６２１ ９０１．８ ９８５ １３３．５ ７．４ １２１．９ ０．２
６ L １，０１４ ２２．５ ４５．１ ８，１９０ ２９．９ ２７４ ４５５ ３２．４ １４．０ ６５，０９０ ５３４ １２２ ８．７ ０．７
７ L ２６７ １１．４ ２３．４ １４２ ４．９ ２９．０ １３，０３６ ６９６ １８．７ ４２，１８９ ６４０ ６５．９ ３．５ １．４
８ R １，５４０ １０．８ １４３ １３８ １７．９ ７．７ １５，５２２ １７６ ８８．２ ２，７８０ ６９０ ４．０ ２２．０ ０．２
９ R ３，６６０ １２．７ ２８８ １３５ ８．９ １５．２ ３，１７１ ４５．２ ７０．２ ２，４６５ ４０９ ６．０ １１．７ ０．３
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Clinical study of ９ cases of primary aldosteronism
performed with selective adrenal venous sampling
Kanako NAKAUCHI１）, Yu MIYAI１）, Eri KONDO１）, Yoshiko KANEZAKI１）, Yasumi SHINTANI１）,
Keiko MIYA１）, Masaya IKUNO２）, Chihiro SHIMIZU２）, Mitsuhiro KINOSHITA２）, Shizuo IKEYAMA２）,
Ryozo SHIRONO２）, Shinichiro KINOUCHI３）, Toshinori KASAI３）, Kenzo UEMA３）
１）Division of Metabolism and Endocrinology, Tokushima Red Cross Hospital
２）Division of Radiology, Tokushima Red Cross Hospital
３）Division of Urology, Tokushima Red Cross Hospital
We evaluated the clinical characteristics and endocrine function of９ patients（mean age,５８ years）with pri-
mary aldosteronism（PA）performed with selective adrenal venous sampling（AVS）. PA was suspected on the
basis of the presence of juvenile or refractory hypertension, hypokalemia or adrenal incidentaloma, and plasma
aldosterone concentration（PAC）／plasma renin activity（PRA）ratio over２００. AVS was performed in all cases.
By using the absolute PAC value stimulated by adrenocorticotropic hormone（ACTH）, ７１％ of the patients
met the diagnostic criteria for PA. In ４ cases that met both absolute and relative criteria for PA, a tumor
was identified in the same side by computed tomography（CT）. However, ３ cases did not meet the criteria,
and PA was diagnosed by image analysis, diurnal variation of PA, or responsiveness of PA in AVS. As clinical
characteristics and endocrine function of PA vary among cases, diagnostic procedures generally start after PA
is clinically suspected. Localization by AVS in combination with ACTH overloading is essential to select an op-
timal treatment method for PA.
Key words : adrenal venous sampling（AVS）, primary aldosteronism（PA）, aldosterone-producing adenoma（APA）
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